The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.
Immune-inflammatory skin diseases (e.g., psoriasis, atopic dermatitis) involve dysregulation of CD4+ T-cell subsets (Th1/Th2/Th17/Treg) and cytokine networks (IL-17/IL-23/IL-4). Biologics targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback